Verified stock metrics
Contineum Therapeutics Key Stock Metrics
Direct answer
Contineum Therapeutics has 7 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked October 13, 2026.
Get free Contineum Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $316.77M
- Price-to-book ratio
- 1.32x
- Return on equity
- -28%
- Dividend yield
- 0%
- 52-week price range
- $8.10 to $17.79
- Profit margin
- 0%
- Debt-to-equity ratio
- 2.74%
Explore related company data
View Contineum Therapeutics's market capitalizationView Contineum Therapeutics's price-to-book ratioView Contineum Therapeutics's return on equityView Contineum Therapeutics's dividend yieldView Contineum Therapeutics's 52-week price rangeView Contineum Therapeutics's profit marginView Contineum Therapeutics's debt-to-equity ratioReturn to Contineum Therapeutics profile